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Abstract
Background: Bluetongue virus (BTV) particles consist of seven structural proteins that are
organized into two capsids. In addition, BTV also encodes three non-structural (NS) proteins of
which protein 2 (NS2) is the RNA binding protein and is also the major component of virus
encoded inclusion bodies (VIBs), which are believed to be virus assembly sites. To investigate the
contribution of NS2 in virus replication and assembly we have constructed inducible mammalian
cell lines expressing full-length NS2. In addition, truncated NS2 fragments were also generated in
an attempt to create dominant negative mutants for NS2 function.
Results: Our data revealed that expression of full-length NS2 was sufficient for the formation of
inclusion bodies (IBs) that were morphologically similar to the VIBs formed during BTV infection.
By using either, individual BTV proteins or infectious virions, we found that while the VP3 of the
inner capsid (termed as "core") that surrounds the transcription complex was closely associated
with both NS2 IBs and BTV VIBs, the surface core protein VP7 co-localized with NS2 IBs only in
the presence of VP3. In contrast to the inner core proteins, the outer capsid protein VP2 was not
associated with either IBs or VIBs. Like the core proteins, newly synthesized BTV RNAs also
accumulated in VIBs. Unlike full-length NS2, neither the amino-, nor carboxyl-terminal fragments
formed complete IB structures and each appeared to interfere in overall virus replication when
similarly expressed.
Conclusion: Together, these data demonstrate that NS2 is sufficient and necessary for IB
formation and a key player in virus replication and core assembly. Perturbation of NS2 IB formation
resulted in reduced virus synthesis and both the N terminal (NS2-1) and C terminal (NS2-2)
fragments act as dominant negative mutants of NS2 function.
Background
In a number of animal and plant viruses the replication
and transcription complexes as well as nucleocapsids,
assembly intermediates and virions, accumulate in spe-
cific virus induced structures within the host cell cyto-
plasm described as 'virus assembly factories' or 'virus
inclusion bodies' (VIBs) [1-6]. Similar to other members
of the Reoviridae family, orbiviruses use such specific sites
for virus replication and the assembly of virion particles.
Bluetongue virus (BTV), the prototype orbivirus, enters
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the host cells via the two outer capsid proteins, its receptor
binding protein VP2 and penetration protein VP5 [7-9].
Once the virion is internalized, both outer capsid proteins
are lost within the endosome and the core, consisting of
two major (VP3 and VP7), three minor enzymatic (VP1,
the viral polymerase; VP4, the capping enzyme and VP6,
the helicase) proteins and a genome of ten double-
stranded RNA (dsRNA) segments, is released into the
cytoplasm. The released core becomes very rapidly associ-
ated with a matrix that gradually surrounds the particles to
form VIBs. As the infection progresses, these VIBs increase
both in size and number and appear to be the sites of orbi-
virus replication and early viral assembly [5,10-12]. This
has largely been inferred from electron microscopy data
on the localization of incomplete virus particles within
VIBs.
Beside the seven structural proteins, BTV also produces
four non-structural proteins (NS1, NS2, NS3 and NS3A)
in infected cells. Recently it has been reported that NS1,
which is produced abundantly in infected cells is involved
in viral morphogenesis, and the two smallest proteins,
NS3 and NS3A are involved in virus egress [13,14]. The
involvement of the 41 kDa NS2 in virus assembly is also
gradually being delineated. NS2 is the only BTV protein
that undergoes phosphorylation [15,16]. It is a highly
charged hydrophilic protein and exists as a 7S multimeric
complex [17-22]. NS2 possesses a single-stranded RNA
binding activity and also has a nucleotidyl phosphatase
activity [23,24]. These observations suggest that NS2 may
have a role in the recruitment and/or retention of RNA for
replication.
Expression of BTV NS2 in both, insect and mammalian
cells, results in the formation of inclusion bodies (IBs)
that are indistinguishable from the VIBs found in virus-
infected cells, indicating that NS2 is the major component
of the VIBs [17,25,26]. To date, the distribution and local-
ization of BTV proteins and RNAs within the infected cell
have mainly been studied by electron microscopy [27].
However, the correlation between what is observed and
what is occurring at the molecular level is relatively poor.
Nevertheless, the presence of the core, nucleic acids and
morphogenic intermediates at the periphery of the VIBs
has led to the proposal that replication and assembly of
BTV take place within this electron dense structure [12]. In
this study we provide experiments to confirm, extend and
substantiate the role of NS2 in virus assembly and replica-
tion. We describe the generation of several inducible
mammalian cell lines expressing complete NS2 as well as
different fragments of NS2 including a fragment consist-
ing of the major RNA binding domains [19,21,28,29].
Analysis of these stable cell lines have confirmed that NS2
alone induces the formation of IBs similar to VIBs in BTV
infected cells and that they are also capable of recruiting
viral core proteins and mRNAs. The IB function of NS2 is
essential for virus replication and correct trafficking. Infec-
tion of cell lines expressing truncated fragments not only
interferes with virus replication but also alters the cellular
distribution of BTV particles in accordance with this
model.
Results
Expression of full-length NS2 in mammalian cells is 
sufficient for IB formation
In order to generate sufficient level of NS2 protein in the
absence of other BTV proteins, a mammalian cell line
which expresses NS2 has been established using a Tet-off
inducible expression system. This is a stringent and tightly
controlled gene expression system where the removal of
doxycycline from the culture media results in high level
transcription of the cloned gene. The full-length NS2 gene
was PCR amplified and cloned into pTRE2-Hyg vector,
transfected into BSR cells and stable cell lines were
selected in the presence of hygromycin as described in the
Materials and Methods. Generation of cell lines was con-
firmed by RT-PCR using specific pairs of primers (data not
shown) and ultimately the production of protein was con-
firmed by radiolabeling and immunoprecipitating the
expressed proteins (Fig. 1A).
To examine whether the NS2 expressing cells synthesize
structures resembling VIBs, cells were analyzed by
immunofluorescence using anti-NS2 antibody (Fig. 1B).
The presence of different sizes of globular, dense inclu-
sions was easily detectable in the cells expressing NS2 in
the absence of doxycycline. These structures morphologi-
cally resemble VIBs in BTV infected BSR cells but the sizes
in the latter appear to be larger and comparatively less
scattered. The globular structures, in the case of the NS2
expressing cells, were not produced in the presence of 1
μg/ml doxycycline (data not shown), which suppresses
NS2 protein expression. These results demonstrate that a
continuous mammalian cell line with regulated expres-
sion of full-length NS2 protein was constructed.
Formation of NS2 IBs is not dependent on either cellular 
microtubule network or intermediate filaments
A previous electron microscopy (EM) study has shown
that during BTV infection virus-like particles and VIBs
were associated with the intermediate filament compo-
nent of cytoskeleton and not with intact microfilament or
microtubule structures [27]. To investigate if the IBs pro-
duced by the stable cell lines behave in a similar manner
we undertook an immunofluorescence study in the pres-
ence and absence of nocodazole, a microtubule depolym-
erizing drug. If IBs formation is dependent on tubulin,
depolymerization should interfere in the formation and
migration of IBs during the dynamic stage of production.
For comparison we included BTV infected cells in parallel.
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We chose to treat the cells with drug at 5 and 15 h post-
infection (p.i) since high density of VIBs are commonly
visible in BTV infected cells between 12 and 16 h p.i [12].
From figure 2A it was evident that there was no obvious
disruption or reorganization of IB formation between
untreated cells or drug treated cells. The distribution of
punctuate structures of NS2 IBs in NS2 expressing cells or
VIBs in BTV infected cells were not affected by presence of
nocodazole, although the ordered arrangement of micro-
tubules compared to untreated cells was significantly dis-
rupted (Fig 2A, upper and lower panels, right columns).
Thus, the data indicate that NS2 IB formation is not
dependent on cellular microtubules similar to that of BTV
VIBs. This result also confirmed a previous finding from
EM studies that microtubules were not involved in inclu-
sion body morphogenesis [27].
For other members of the family a clear association
between the virus particle, inclusions and the intermedi-
ate filament protein vimentin has been shown which was
accompanied by significant changes in the vimentin fila-
ment network of the cells resulting in a sheath-like struc-
ture surrounding the inclusions [30]. To determine
whether this association applied to NS2 IBs and if IBs in
NS2 cells have similar effects on vimentin, NS2 expressing
cells and BTV infected cells (control), were labeled with
anti-vimentin monoclonal antibody (Fig. 2B, green) and
anti-NS2 polyclonal antibody (Fig. 2B, red). The distribu-
tion of respective proteins was visualized by fluorescence
microscopy. Unlike reoviruses, neither NS2 IBs nor BTV
induced VIBs were surrounded by cage-like structures.
This suggests that the filament network of cells is not
involved in VIB formation and that NS2 IB, like VIB, does
not require these filaments.
The core proteins of BTV, but not the outer capsid protein 
VP2, is targeted to NS2 IBs
To investigate whether NS2 alone is sufficient to recruit
the viral structural proteins into the IBs, we have moni-
tored the localization of three major viral structural pro-
teins; VP2 (outer capsid), VP7 (surface core protein) and
VP3 (inner core protein that encapsidates the polymerase
complex and viral genome). Each protein was expressed
by transfecting plasmids into either control BSR cells
(uninduced NS2 cells) or BSR cells expressing NS2 protein
(induced NS2 cells). In addition, normal BSR cells
infected by BTV were also used for comparison. The distri-
bution of each protein was examined by immunofluores-
cence microscopy using anti-VP2, anti-VP3 or anti-VP7
antibody and inclusions were identified by using anti-NS2
antibody. When the distribution of NS2 and VP2 were
monitored in NS2-BSR cells at 24 h post transfection by
confocal microscopy (Fig. 3A, middle panel) no co-local-
ization of VP2 and NS2 IBs could be detected and VP2 was
Full-length NS2 expression by constitutive BSR cells and its intracellular distributionigure 1
Full-length NS2 expression by constitutive BSR cells and its intracellular distribution. (A) Radiolabeled lysate of 
uninduced (left lane) and induced WT-NS2 cell line (right lane) were immunoprecipited using polyclonal anti-NS2 antibody. 
The names of the cell lines are given at the top of the panel. The position of NS2 fragment is indicated. (B) Cells expressing 
NS2 in absence of doxycycline (left) and unmodified BSR cells (right) infected with BTV-10 at 24 h p.i were immunolabeled with 
an anti-NS2 polyclonal antibody (green). Nuclei were stained with Hoechst 33342.
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distributed throughout the cytoplasm, similar to the con-
trol BSR cells (Fig. 3A, left panel). Further, when the dis-
tribution pattern of VP2 in NS2 expressing cells was
compared with BTV infected cells (Fig. 3A, right panel),
again no difference in VP2 distribution could be detected.
Therefore the presence of other BTV components did not
influence the VP2 intracellular localization.
In contrast, the distribution of VP7 in NS2 expressing cells
was different to its distribution in BTV infected cells.
Although VP7 was distributed throughout the cytoplasm
in NS2 expressing cells similar to the control, uninduced
BSR cells (Fig. 3B, left and middle panels), the distribu-
tion of VP7 was markedly different in BTV infected cells at
24 h p.i. All VIBs showed co-localization between NS2
and VP7, although there were also some foci of VP7 out-
side of VIBs (Fig. 3B, right panel). Evidently intracellular
VP7 distribution is influenced by the presence of other
BTV proteins.
In contrast to VP2 and VP7, the distribution of VP3 rela-
tive to IBs was strikingly different. In microscopy studies
VP3 was exclusively localized within the VIBs in both NS2
expressing cells and in BTV infected cells (Fig. 3C, middle
and right panels). The result was similar to that obtained
recently with an EGFP tagged VP3 protein in BTV infected
BSR cells [26]. These results are not surprising since VP3 is
closely associated with the three core proteins (VP1, VP4
and VP6) that form the transcription complex and the
BTV ssRNA. This complex subsequently generates the
assembly intermediate, the single layered subcore particle
which takes place within the VIBs. This data also con-
firmed our previous study that used transient expression
of NS2 and core proteins [25]. Along with the previous
publication, these data support the conclusion that unlike
VP7, VP3 and inner transcription complex are closely
associated with NS2 and VIBs. VP7 only associates with
NS2 and VIBs through its interaction with VP3 or other
BTV components. However, VP2 is never recruited within
the VIBs.
The distribution of VP7 in IBs alters in the presence of 
scaffolding protein VP3
To further our understanding of the influence of VP3 on
VP7 assembly, we monitored the distribution pattern of
both VP7 and VP3 in the presence of NS2 in BSR cells.
NS2 expressing cells were co-transfected with plasmids
expressing VP7 and VP3 and processed for immunostain-
ing as described in the Materials and Methods. Both VP7
and VP3 were labeled with specific antibodies (Fig. 3D).
The distribution of VP7 altered dramatically when co-
expressed with VP3 in the NS2 expressing cells (Fig. 3D).
Both VP3 and VP7 were perfectly co-localized in a pattern
that closely resembled the pattern of NS2 IBs in the cyto-
plasm. The overall size of these IBs (VP3+VP7+NS2) was
larger than that of NS2 IBs when NS2 was expressed singly
or when BTV proteins were not associated with NS2 IBs
(See Fig. 1 & Fig. 3A, middle column). It could be specu-
NS2 IB does not associate with microtubule or vimentinFigure 2
NS2 IB does not associate with microtubule or 
vimentin. (A) BSR cells infected with BTV-10 (upper panel) 
at 5 h p.i or modified BSR cells expressing NS2 (lower panel) 
were treated with nocodazole (right column) to disrupt 
microtubule. NS2 (green) and microtubule (red) were moni-
tored. Untreated cells labeled for microtubule and NS2 (left 
column) were used as controls. (B) NS2 expressing cells 
(right) and BSR cells 24 h p.i were labeled for vimentin 
(green) and NS2 (red). Un-transfected and uninfected cells 
labeled for vimentin (left) were used as control.
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Sub-cellular localization of BTV VP2, VP7 and VP3 in NS2 expressing or BTV infected BSR cellsFigure 3
Sub-cellular localization of BTV VP2, VP7 and VP3 in NS2 expressing or BTV infected BSR cells. (A) Distribution 
of VP2 (green) and NS2 (red) in BSR cells transfected with plasmids expressing VP2 and NS2 (middle) or infected with BTV-10 
(right). (B) Localization of VP7 (green) and NS2 (red) in transfected (middle) and infected cells (right). (C) Expression of VP3 
(green) and NS2 (red) in transfected (middle) and infected cells (right). (D) Co-localization of VP7 (green) and VP3 (red) in full-
length NS2 expressing BSR cells co-transfected with plasmids expressing VP7 and VP3. BSR cells transfected with VP2, VP7 and 
VP3 were used as controls (left column in A, B and C).
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lated that this is due to the presence of both VP3 and VP7
in NS2 IBs, thus increasing the overall sizes of NS2 IBs.
RNA transcription takes place in NS2 IBs of a BTV infected 
cell
BTV positive strand RNA directs both protein synthesis
and production of minus-strand RNA. In BTV infected
cells the transcriptionally active core particles become rap-
idly surrounded by VIBs upon entry into the cytoplasm
[27]. Since NS2 has an affinity for BTV transcripts [20] and
is likely to be involved in the recruitment of viral tran-
scripts, we sought to examine if the viral transcripts could
be identified within the VIBs. BTV infected cells were
treated with actinomycin D, to arrest the host replication
and transcription, followed by transfection with BrUTP as
described in Materials and Methods. We chose 14 h p.i for
BrUTP transfection since the formation of VIBs in BTV
infected cell was maximal between 12 and 16 h p.i. After
fixation with formaldehyde newly made RNA was visual-
ized by staining with anti-BrdU antibody and the NS2
inclusions were located using anti-NS2 polyclonal anti-
body. The BrdU-labeled RNA transcripts were distributed
throughout the NS2 IBs suggesting that these are the likely
sites for RNA replication (Fig. 4). BTV infected BSR cells in
the absence of BrUTP were used as control and no BrdU
signal was detected in these cells upon labeling with anti-
BrUTP antibody, thus confirming its specificity (data not
shown).
Inducible expression of truncated NS2 derivatives in 
mammalian cells
Upon confirmation of the fact that BTV core proteins, par-
ticles and transcripts were closely associated with NS2 and
IBs formed by NS2, we extended our study to examine the
role of NS2 in overall virus replication. To this end, we
sought to obtain dominant negative mutants of NS2 in
order to perturb the NS2 function. Deletion mutants of
NS2 protein were designed in four overlapping fragments,
residues 1–115 (ΔNS2-1), 116–357 (ΔNS2-2), 1–237
(ΔNS2-3), and 238–357 (ΔNS2-4) (Fig. 5A). BSR cell lines
expressing each fragment constitutively were generated as
described for the full-length NS2. The constitutive expres-
sion of each NS2 mutant fragment was determined by
pulse labeling with 35S-methionine/cysteine and the
labeled protein was immunoprecipitated with anti-NS2
BTV polyclonal antibody. The expression levels of each
the truncated NS2 fragments when examined by SDS-
PAGE was much lower than that of the full-length NS2
(Fig. 5B). In addition to the predicted molecular weight
fragment of 1–115 (ΔNS2-1), an additional smaller break-
down product was also precipitated. To examine the capa-
bility of these NS2 fragments to produce IBs, cells
expressing each NS2 truncation were labeled with the NS2
antibody and the distribution of IBs visualized by fluores-
cence microscopy. None of the truncated versions of NS2
could form the large IBs characteristic of BTV infection or
like that of full-length NS2 (compare Fig. 1 with Fig. 5C).
Instead the truncated NS2 proteins were found spread
throughout the cell cytoplasm in a diffuse manner except
ΔNS2-2, which exhibited some granular staining pattern
(Fig. 5C). In all cases, the dispersed distribution of NS2
antigen completely disappeared in the presence of 1 μg/
ml doxycycline indicating the absence of NS2 protein syn-
thesis in the presence of the drug (data not shown). These
results suggest that the capability to form IB is a function
of the complete NS2 protein. Expression levels of the trun-
cated NS2 proteins in ΔNS2-3 and ΔNS2-4 cell lines were
found to be variable in the individual cells as indicated by
the arrow (Fig. 5C). Due to this heterogeneity in protein
expression these two cell lines were not used in subse-
quent experiments.
Inhibitory effects of NS2 fragments on BTV infection
To investigate the effect of NS2 deletion mutants, cell line
expressing full-length WT-NS2, ΔNS2-1 or ΔNS2-2 were
infected with BTV and the level of infectious virus produc-
tion in each case was monitored by plaque assay (in trip-
licates). The overall yield of infectious BTV particles,
isolated from the culture media and the infected cell
lysates of induced WT-NS2, was very similar to that of BTV
infected normal BSR cells or uninduced cells (Table 1), as
was the relative proportions of virus present in the cell-
associated and supernatant fractions. However, when cell
lines expressing the truncated NS2 were infected with
BTV, both cell lines showed a reduced overall titre suggest-
ing a trans-dominant inhibitory effect on virus replica-
tion. Moreover, in the case of ΔNS2-1, the overall titre was
marginally reduced and the ratio of secreted to cell-associ-
ated virus titre increased about 1000 fold, while cell lines
expressing ΔNS2-2 appeared to more powerfully inhibit
overall virus replication.
To investigate this observation further, a pulse-chase anal-
ysis of each cell line was performed at 14 h p.i with BTV to
assess the rate of virus movement through the cells. A 2 h
labeling pulse was chased for 30 min, 1 h, 3 h, 5 h, 7 h and
10 h and at each time point both cell lysates and extra-cel-
lular media were collected and BTV antigens identified by
immunoprecipitation. Compared to the normal viral
release as observed in WT-NS2 (Fig. 6 panel A), virus pres-
ence in the extra-cellular media of the ΔNS2-1 (aa1-115)
cells was identifiable at very early time points (Fig. 6 panel
B). The kinetics of virus release from ΔNS2-2 cells (panel
C) resembled that of the full-length NS2 cell line (panel
A), although the overall titre was considerably reduced
(cf. panel A).
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Expression of only the RNA binding amino-terminal region 
of NS2 alters the BTV egress from the infected cell
To examine further the effect of amino and carboxyl ter-
minus truncation on IB formation and on BTV release, we
examined each cell line following infection with BTV by
EM. Negative staining of thin sections of BSR cells infected
with BTV for 24 h prior to processing shows particulate
structures with dimension ~70 nm (Fig. 7A). These struc-
tures were similar to BTV core particles and appeared to be
surrounded by VIBs (Fig. 7A). Often these particles
appeared to be released from the VIBs in a cluster (Fig. 7A
right). Particles with similar sizes were also seen within
the VIBs of the WT-NS2 cells that were infected with BTV
(Fig. 7B). In contrast to the full-length NS2 expressing
cells or normal BSR cells, cells expressing ΔNS2-1 showed
release of particles resembling the BTV virion from the cell
membrane, but very few, if any large VIBs (Fig. 7C). Thus,
the normal virus egress pathway in mammalian cells was
altered drastically due to the absence of IBs. Although in
case of cells expressing ΔNS2-2, small granular bodies
were observed, very few virus particles could be detected
in the infected cells (data not shown).
Discussion
The interaction of viral proteins and the recruitment of all
the necessary components for de novo genomic RNA syn-
thesis and viral core assembly have only recently begun to
be illuminated. Reports from different laboratories,
including this one, have shown that the different non
structural proteins of diverse members of the Reoviridae
family are involved in the formation of cytoplasmic inclu-
sions that resemble viral IBs [17,31,32]. Despite the lack
of sequence homology, functional analysis of rotavirus
NSP2 (35 kDa) and reovirus protein σNS (41 kDa) sug-
gests that they may be homologues of BTV NS2 as all three
proteins have been implicated in viral genome replication
and/or packaging [17,20,33]. Direct analysis of infected
cells is limited by the fact that all viral proteins are con-
stantly present and the distinction between proteins that
are free in the cytoplasm or partially inclusion associated
is difficult. In this study we created cell lines constitutively
expressing BTV NS2 proteins, the main determinant of the
viral inclusion formation, by using the Tet-Off inducible
expression system, specifically to examine the association
of NS2 with BTV structural proteins in the absence of the
complete viral replication-cycle. It is known that BTV
structural proteins have inherent affinities for each other
as single, double or triple layered capsids can assemble in
insect cells in the absence of NS2 or VIB formation
[34,35]. However, in that system the concentration of
structural proteins is very high and may obviate the need
for facilitating molecules. A very similar phenomenon is
observed with the assembly and release of retroviral cap-
sids which proceeds following baculovirus expression
without the P6 resident PTAP domain required for physi-
ologically relevant assembly [36]. Thus, a plausible role
for the VIBs in virus infected cells might be to coordinate
the formation of infectious particles by the recruitment of
all the essential structural components followed by the
sequential packaging of viral genomes.
Inducible cells expressing NS2 were used to investigate
which structural proteins associate with NS2 IBs in the
absence of other BTV components. From this analysis it
was clear that when the major BTV structural proteins
were co-expressed singly with NS2, only the inner core
protein VP3 co-localized with NS2 IBs. Neither VP7 nor
VP2 protein was found to be associated with IB structures.
Intracellular sites of RNA synthesis in BTV infected cellsFigur  4
Intracellular sites of RNA synthesis in BTV infected cells. Co-localization of NS2 (green) and BrUTP labeled RNA (red) 
in BSR cells infected with BTV-10 (MOI of 1) 17 h p.i. The cells were treated with actinomycin D prior to immunostaining.
NS2 BrdU Merge
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Expression of NS2 mutants constitutively in BSR cellsFigure 5
Expression of NS2 mutants constitutively in BSR cells. (A) Schematic representation of various NS2 carboxyl- and 
amino-terminal deletions used to produce inducible mammalian cell line (BSR). (B) Immunoprecipitation of radiolabeled pro-
teins. Radiolabeled cell lysates of the different NS2 cell lines (BSR) were immunoprecipited using polyclonal anti-NS2 antibody. 
The names of the cell lines are given at the top of the panel. The positions of the various NS2 fragments are indicated. (C) 
Intracellular distribution of NS2 fragments (green) in inducible NS2 cell lines (BSR). The name of each mutant is indicated.
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Table 1: Infectious BTV particles produced in NS2 expressing BSR cells
Cell Lines Intracellular Extracellular
BSR/UNINDUCED 5.0 × 107 2.3 × 102
WT-NS2 8.1 × 107 4.8 × 102
ΔNS2-1 7.1 × 106 3.8 × 104
ΔNS2-2 8.6 × 104 8.2 × 102
BSR cells, full-length NS2 cell lines (induced and uninduced) and two cell lines expressing NS2 fragments were infected with BTV-10 at MOI of 0.1. 
Released and intracellular virus titres at 24 h p.i were monitored by plaque assay. The values given here are an average of three different sets of 
plaque assay data.
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However, when VP7 was expressed in the presence of VP3,
VP7 was readily moved into the NS2 IBs. Thus, VP7 inter-
acts spontaneously with VP3 to generate the core and
assembly occurs predominantly at the site of VP3 accre-
tion with NS2. The data also support our earlier findings
which showed that VP3 and the three minor proteins that
form the BTV transcription complex were always seen
together with NS2 IBs when cells were transfected with
NS2 plasmids or infected with BTV [25]. Together with
our previous report and this current study we suggest that
NS2 IBs recruit newly synthesized VP3 and the minor pro-
tein enzyme complex, soon after synthesis, in order to
enucleate the essential components for virus replication.
This model was further substantiated by demonstrating
that the newly synthesized BTV transcripts were also local-
ized within the NS2 IBs. This data is consistent with the
data described recently which has shown that NS2 has
specific binding affinity for BTV transcripts [20]. It seems
therefore likely that NS2 IBs are the site where the co-
assembly of VP3, the polymerase complex and plus strand
BTV RNA species takes place. Studies of VP7 assembly
onto the VP3 subcore have suggested that enshrouding
begins at a number of discrete sites on the VP3 shell rather
than one unique site [37]. Thus, either during subcore
assembly or after completion of subcore formation, VP7
'T' trimers begin to attach to the VP3 subcore. The core
particle subsequently forms a stable structure ready to
release from the VIBs. During BTV infection subcore-like
and core-like particles have been observed in IBs by scan-
ning electron microscopy [5]. Neither outer virion struc-
tural protein, VP5 or VP2, have affinity for IBs and
therefore progeny core particles produced in the VIBs
most likely move to periphery of the VIB to be coated by
the outer capsid proteins [12]. Interestingly, VP2 has been
shown to be associated with the cell cytoskeleton [38].
The eukaryotic cytoskeleton network undergoes consider-
able rearrangement following infection by certain viruses
such as African Swine Fever Virus (ASFV) [39], Vaccinia
virus [40] and reovirus [30,41].
Some reovirus strains show selective and temporally regu-
lated association of the cytoskeleton with the assembly
site [42], and most mammalian reovirus strains form
microtubule associated filamentous factories [31]. By con-
trast, visualization of BTV infected or NS2 expressing cells,
by immunofluorescence, revealed that VIBs and NS2 IBs
are globular cytoplasmic inclusions and are not associated
with cytoskeleton. Most conclusively, the treatment of
cells with a MT-depolymerizing agent, nocodazole, clearly
indicated that there was no effect of the drug on VIBs for-
mation in the cytoplasm.
To substantiate further the importance of NS2 and IBs in
BTV replication, we generated cell lines expressing NS2
fragments. Two cell lines, one expressing amino terminal
fragment and other carboxyl terminal fragment of NS2
fragments were utilized. The amino terminal 115 residues
Immunoprecipitation of the BTV proteins in NS2 cell linesFigure 6
Immunoprecipitation of the BTV proteins in NS2 cell 
lines. Immunoprecipitation of BTV-10 proteins in NS2 cell 
lines; WT-NS2 (A), ΔNS2-1 (B) and ΔNS2-2 (C) were 
infected with BTV-10 and the lysates were precipitated by a 
polyclonal BTV antisera. The names of the fractions and post 
chase times are indicated at the top of the panel. Note the 
early virus release in ΔNS2-1 cells in compared to that of the 
other two cell lines as indicated by arrows.
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in NS2 have already been shown to contain the predomi-
nant RNA binding domain of the protein and thus may
delineate functional boundaries within NS2 [20,28,29].
Neither fragment formed complete IBs alone but our data
suggest that cells expressing the C-terminal fragment of
NS2 (residues 116–357) were capable of limited NS2
antigen aggregation (punctuate as opposed to wholly dif-
fuse staining in ΔNS2-1 cells). Protein-protein interac-
tions via the C terminal portion of NS2 would be
consistent with RNA interactions predominantly via the
N-terminal 115 residues [28,29]. When the cell lines
expressing WT-NS2 were infected with BTV, the constitu-
tive expression of the complete molecule did not have a
significant effect on virus yield nor on the distribution of
virions between the cell and supernatant. However, BTV
infection of the two cell lines expressing NS2 fragments
lead to a marked reduction in overall virus yield possibly
because both fragments act as dominant negatives
through an interaction with the full-length virally
expressed NS2. In addition, the relative proportion of
virus released from the cell and the kinetics of release were
altered. As revealed by pulse-chase and EM of infected
Transmission electron micrographs illustrating VIBs and BTV distribution in BTV infected normal BSR and NS2 expressing cellsFigure 7
Transmission electron micrographs illustrating VIBs and BTV distribution in BTV infected normal BSR and 
NS2 expressing cells. (A) BTV-10 infected BSR cells, (B) full-length NS2 expressing cells and(C) ΔNS2-1 expressing cells 
were analyzed by transmission electron microscopy 24 h p.i. Normal infection of BTV particles are amplified (A right panel) to 
indicate the newly synthesized particles (indicated by arrows). Bar = 0.5 μm.
BSR-BTV
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cells, ΔNS2-1 cell line expressing the RNA binding region
of NS2 severely crippled the ability of NS2 to form IBs and
promoted accelerated trafficking of the progeny virus par-
ticles. It is known from our previous study that the inter-
action between RNA and NS2 plays a role in the stable
oligomerisation of NS2 [25]. Hence, it can be hypothe-
sized that perhaps ΔNS2-1 competes with the RNA bind-
ing activity of full-length NS2 and thereby perturbs the
stability of VIBs which requires NS2-RNA interactions. In
the case of ΔNS2-2, although the expression of small gran-
ular bodies could be observed, they were morphologically
different to the functional inclusions formed by full-
length NS2. Nevertheless, these small structures have the
ability to interact with monomeric NS2 thereby interfer-
ing with the function of VIBs in virus replication. Thus,
both mutants have the ability to perturb the normal virus
replication and trafficking although the exact molecular
basis behind these phenomena is not yet understood.
Conclusion
The IBs or virosomes produced in BTV infected cells have
been the subject of some debate, split broadly between
them being integral to virus replication and assembly or
being the inadvertent consequence of another primary
function [20]. Our work shows that their previously
described complexity (showing the presence of many
structural and non-structural proteins) is a result of their
key role in the recruitment of viral components. Their
make-up is dependent only on a full-length NS2 with the
C terminus of the protein being the major functional
domain involved. NS2 has an innate propensity to inter-
act with VP3, the inner core protein and through this has
the ability to interact with VP7, the surface core protein.
RNA binding by the amino terminal domain would com-
plete the requirements for core formation and completed
cores, now protected from the possibility of inducing an
interferon response, would then be free to acquire the
outer layers (VP5 and VP2) outside the IB structures. The
data implies that replication and assembly are coordi-
nated events in the IBs. The definition of the precise order
of events required for completing BTV assembly and
release, with the accompanying increased possibilities for
prevention and control, remains an unfinished but
achievable goal.
Methods
Virus and cells
BTV serotype 10 was plaque purified and propagated as
described elsewhere [43]. BSR cells, a derivative of Baby
hamster kidney cells (BHK), were maintained in Dul-
becco's modified Eagle's medium (DMEM) supplemented
with 10% fetal calf serum, penicillin and streptomycin.
BSR Tet-Off cells were maintained as described above with
the addition of antibody G418 sulphate to a final concen-
tration of 100 μg/ml. BSR-NS2 cells were maintained in
the same manner as BSR Tet-Off cells but with the addi-
tion of hygromycin to 100 μg/ml and doxycycline to 1 μg/
ml.
DNA manipulation and construction of DNA clones
Plasmid DNA manipulation was done essentially as
described [44]. Restriction enzymes, T4 DNA ligase, DNA
polymerase were purchased from New England Biolabs
(NEB) and calf intestinal alkaline phosphatase was
obtained from Roche (Germany).
Construction of mutant NS2 genes and generation of 
inducible 'Tet Off' cell line
We used the following primers to clone NS2 mutants; for-
ward primer 5' CGGGATCCCGAAATCCTTGAGTCAT-
GGAGC 3' and reverse primer 5' CGGGATCCCG
GTAAGTGTAAAATCCCCCC 3' for WT-NS2; forward
primer 5' CGGGATCCCGAAATCCTTGAGTCATGGAGC
3' and reverse primer 5' CGGGATCCCGTTAAACCAT-
CACACCATTATACTGTAC 3' for ΔNS2-1; forward primer
5' CGGGATCCCGATGGACGCTGAAATTAAATACTG-
TAAG 3' and reverse primer 5' CGGGATCCCGGTAAGTG-
TAAAATCCCCCC 3' for ΔNS2-2; forward primer 5'
CGGGATCCCGAAATCCTTGAGTCATGGAGC 3' and
reverse primer 5' CGGGATCCCGAAATCCTTGAGTCAT-
GGAGC 3' for ΔNS2-3; forward primer 5' CGGGATC-
CCGATGTTTAAAGAGGTGGAAGC 3'and reverse primer
5' CGGGATCCCG GTAA GTGTAAAATCCCCCC 3' for
ΔNS2-4. These BamH I cut PCR products were then ligated
into the BamH I site of pTRE2-Hyg (Clonetech) and used
to transfect BSR Tet-Off mammalian cells (Clonetech).
Stable cell lines expressing desired protein were selected
using 200 μg/ml hygromycin and subsequently main-
tained with 100 μg/ml hygromycin.
Labeling mammalian cells and immunoprecipitation
BSR cells expressing NS2 proteins in absence of doxycy-
cline were incubated in medium lacking Methionine and
Cysteine medium for 30 min and then pulsed with 100
μCi of 35S-Met/Cys for 2 h. The cells were harvested,
washed and lysed with radio-immunoprecipitation
(RIPA) buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl,
1% Triton X-100, 0.5% sodium deoxycholate, 1 mM
EDTA), incubated in ice for 15 min and centrifuged at
13,000 × g. Anti-NS2 polyclonal antiserum bound to pro-
tein A agarose beads (Pierce) was used to immunoprecip-
itate the complex form cell lysates. For immunoprcepitation
of BTV proteins in NS2 cell lines, the cells were first
infected with BTV 10 (MOI 0.1) and then processed for
radiolabeling. Both intracellular and extracellular viruses
were collected and subjected to immunoprecipitation
with anti-BTV antibody. All the samples were washed with
RIPA buffer, analyzed by SDS-PAGE and subjected to
autoradiography. NS2 cell lines maintained in the pres-
ence of doxycycline and BSR cells were used as controls.
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Electron microscopy
NS2 expressing and BTV infected cells were pelleted at
2000 rpm for 10 min and fixed in 2.25% (w/v) glutaralde-
hyde 0.1 M cacodylate buffer (pH 7.2) at 4°C for 40 min.
After rinsing the cells were post fixed in 1% (w/v) osmium
tetroxide, buffered in 0.1 M cacodylate buffer (pH 7.2),
washed in water, dehydrated in acetone and embedded in
low viscosity resin. Sections were stained in 2% uranyl
acetate. Stained sections were examined in a Hitachi
H7000 electron microscope.
Immunostaining and IF microscopy
For immunolabeling experiments 1.5 × 105 cells were
seeded the day before infection or transfection in six-well
plates (9.6 cm2 per well) containing 18 mm round glass
cover slips. Plasmids expressing VP2, VP3 or VP7 were
transfected using lipofectamine 2000 (Invitrogen) accord-
ing to manufacturer's recommendations. The cells were
then processed for immunostaining as described previ-
ously [26]. For labeling VP2, the cells were incubated with
anti-VP2 monoclonal antibody, while VP3, VP7 and NS2
were labeled with polyclonal antibodies followed by
appropriate Alexa Fluor 488 (green)/FITC or Alexa Fluor
594 (red)/TRITC conjugated secondary antibodies.
Immunostained cells were washed three times with PBS
incubated with Hoechst 33342 for nuclear staining and
mounted on slides with Vectashield (Vector laboratories).
Immunolabeled samples were examined by Olympus
inverted microscope with fluorescence optics. Images
were collected digitally using IP lab software (Scananalyt-
ics, Fairfax, VA). Hoechst 33342, IgG conjugated to Alexa
Fluor 488 or Alexa Fluor 594 were obtained from Molec-
ular probes. Anti-β tubulin was purchased from Sigma
Chemical Company. Anti-vimentin monoclonal was pur-
chased from Oncogene.
Detection of newly synthesized RNA in vivo by IF
BSR cells were infected with BTV at MOI of 1 for 14 h, fol-
lowed by treatment with actinomycin D (10 μg/ml). After
1 h cells were transfected with 10 mM BrUTP (Sigma)
using 5% FuGene transfection reagent (Roche). Cells were
fixed 17 h pi and processed for IF analysis with mouse
anti-bromodeoxyuridine BrdU monoclonal antisera
(Sigma) followed by Alexa Fluor 594 goat anti-mouse IgG
as secondary antibody.
BTV infectivity assay
Induced NS2 cell lines were infected with BTV-10 at an
MOI of 0.1 and incubated for 24 h at 37°C. Cell superna-
tant and pellets were collected and the cells were subjected
to three freeze/thaw cycles to disrupt cells and release
virus. After all the samples were collected, the viral of each
sample was determined by virus plaque assay in BSR cell
monolayer cultures. Uninduced NS2 cell lines and BSR
cells were infected and processed as described above.
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